Correlation Between Milestone Pharmaceuticals and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Pliant Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Pliant Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Pliant Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Milestone and Pliant is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Pliant Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.42 times more return on investment than Pliant Therapeutics. However, Milestone Pharmaceuticals is 1.42 times more volatile than Pliant Therapeutics. It trades about 0.31 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Pliant Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Pliant Therapeutics |
Milestone Pharmaceuticals and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Pliant Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Pliant Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Pliant Therapeutics vs. Bright Minds Biosciences | Pliant Therapeutics vs. HP Inc | Pliant Therapeutics vs. Intel | Pliant Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |